Viewing Study NCT05388695


Ignite Creation Date: 2025-12-24 @ 1:27 PM
Ignite Modification Date: 2025-12-29 @ 3:13 PM
Study NCT ID: NCT05388695
Status: RECRUITING
Last Update Posted: 2025-06-18
First Post: 2022-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module